NFKB1 and cancer: Future studies that use a systems biology approach to map the myriad of microenvironmental factors on converging pathways in cancer cells (e.g., NF-κB, PI3K-ΑΚΤ) and to identify context-dependent targets hold promise for halting ovarian cancer progression.